News and Media

First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials

First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials

September 29, 2021

ENA Respiratory,a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 and other respiratory viral infections, announced today that it has engaged research partners PPD, Inc. and hVIVO, a division of Open Orphan, to conduct its Phase 2 studies. 
Read More
Certa Therapeutics announces new clinical trial of investigative candidate

Certa Therapeutics announces new clinical trial of investigative candidate

September 22, 2021

Certa Therapeutics has announced the launch of a Phase 2 trial in Australia for a potential new treatment for Diffuse Systemic Scleroderma.
Read More
Survive the journey: PERKii sees steady sales of probiotic drinks made with exclusive encapsulation technology

Survive the journey: PERKii sees steady sales of probiotic drinks made with exclusive encapsulation technology

September 10, 2021

Australian probiotic brand PERKII has seen steady sales of its probiotic beverages amid the pandemic, boosting the firm’s confidence in its overseas expansion plans.
Read More

Is it time for Australia to rethink skilled migration?

Is it time for Australia to rethink skilled migration?

June 08, 2021

Stoic Venture Capital partner Geoff Waring welcomed the Australian government’s proposed review of the tax treatment of venture capital funds as a key measure to help lift the nation’s economy and global competitiveness amid COVID-19, announced during the budget.
Read More
ESG needs better disclosure standards

ESG needs better disclosure standards

June 08, 2021

Fund managers should be subject to more rigorous standards to ensure their disclosures about environmental, social and governance (ESG) investing are accurate, according to Stoic Venture Capital.
Read More
Stoic Venture Capital commits further to healthcare following Cardihab success

Stoic Venture Capital commits further to healthcare following Cardihab success

April 23, 2021

Stoic Venture Capital has committed to further bulking up its healthcare investments as the prevalence of chronic disease such as cardiovascular disease continues to rise.
Read More